FDA Inspection 1220679 — Padagis Israel Pharmaceuticals Ltd.
The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on September 20, 2023 in Yerucham. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 20, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Yerucham (Israel)